RxDoctor Payments DataLook up a doctor →

Derek Menkedick, DO

Neurology · Centerville, OHNPI 1699137364

Payments from drug & device makers

$425,488in general payments, 2019–2025

Across 1,031 payments — averaging $412.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$247K
  • Sanofi$143K
  • EMD Serono, Inc.$19K
  • AbbVie$3K
  • MDD US Operations, LLC$2K
  • Biogen$1K
  • plus $11K from 53 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis72$247,030
Sanofi49$143,022
EMD Serono, Inc.96$18,575
AbbVie(2 entities)148$2,773
MDD US Operations, LLC89$1,800
Biogen46$1,455
Lilly USA, LLC54$796
Genentech USA, Inc.24$790
UCB, Inc.32$727
AstraZeneca(2 entities)28$669
Neurocrine Biosciences, Inc.40$620
Pfizer37$527
TG Therapeutics, Inc.5$484
Teva Pharmaceuticals USA, Inc.21$476
Amneal Pharmaceuticals LLC23$469
Biohaven Pharmaceuticals, Inc.24$409
SK Life Science, Inc.20$406
Amgen(2 entities)19$403
Eisai Inc.13$348
Johnson & Johnson16$333
Acorda Therapeutics, Inc17$329
Lundbeck LLC10$273
Acadia Pharmaceuticals Inc13$236
Argenx US, Inc.10$232
Sunovion Pharmaceuticals Inc.14$202
Takeda Pharmaceuticals U.S.A., Inc.8$198
Jazz Pharmaceuticals Inc.9$161
Avanir Pharmaceuticals, Inc.9$147
Biohaven Pharmaceutical Holding Company Ltd.10$125
Neurelis, Inc.6$120
Sumitomo Pharma America, Inc.6$109
Vanda Pharmaceuticals Inc.5$107
Insightec,inc2$106
Abbott1$95
Ipsen Biopharmaceuticals, Inc6$92
Merz Pharmaceuticals, LLC4$85
Axsome Therapeutics, Inc.4$85
Amylyx Pharmaceuticals, Inc.4$68
Supernus Pharmaceuticals, Inc.5$60
Octapharma USA, Inc.3$59
Greenwich Biosciences, Inc.4$55
Banner Life Sciences, LLC2$42
Adamas Pharmaceuticals, Inc.3$39
Alnylam Pharmaceuticals Inc.2$35
CSL Behring2$29
Kyowa Kirin, Inc.2$27
Boston Scientific1$26
Akcea Therapeutics, Inc.1$26
Revance Therapeutics, Inc.1$26
Vertical Pharmaceuticals, LLC2$24
Sandoz1$22
Philips North America LLC1$22
GE HealthCare1$22
Tanabe Pharma America, Inc.1$19
Cala Health, Inc.1$17
Currax Pharmaceuticals LLC1$15
Tempus AI, Inc1$13
Aprecia Pharmaceuticals, LLC1$13
Harmony Biosciences LLC1$12

How this compares

$425,488 in reported general payments places this provider in the 90th percentile of 702 neurology providers in Ohio.

See all neurology providers in Ohio

Medicare billing

Part B allowed, 2024
$333,116
Medicare patients
493
Services billed
12,579

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Centerville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →